68 GA-FAPI-04 PET/CT Versus 18 F-FDG PET/CT in Imaging of Malignant Mixed Germ Cell Testicular Tumor
- PMID: 36728220
- DOI: 10.1097/RLU.0000000000004530
68 GA-FAPI-04 PET/CT Versus 18 F-FDG PET/CT in Imaging of Malignant Mixed Germ Cell Testicular Tumor
Abstract
18 F-FDG PET/CT imaging was performed for restaging in in a 16-year-old boy who was operated on for right testicular tumor and was diagnosed with malignant mixed germ cell tumor. Mild FDG uptake was observed in 2 nodules in both lungs and retroperitoneal lymph node in the abdomen. 68 Ga-FAPI (fibroblast activation protein inhibitor) 04 PET/CT showed moderate uptake of FAPI in lung nodules and retroperitoneal lymph node. In this case, 68 Ga-FAPI-04 PET/CT was shown to be superior to 18 F-FDG PET/CT in the evaluation of malignant mixed germ cell testicular tumor metastases.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest and sources of funding: none declared.
References
-
- Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin . 2021;71:209–249.
-
- Kitajima K, Yamamoto S, Fukushima K, et al. Update on advances in molecular PET in urological oncology. Jpn J Radiol . 2016;34:470–485.
-
- Farolfi A, Koschel S, Murphy DG, et al. PET imaging in urology: a rapidly growing successful collaboration. Curr Opin Urol . 2020;30:623–627.
-
- Ali I, Johns W, Bottger B, et al. Serendipitous detection of testicular seminoma on F-18 FDG positron tomography. Clin Nucl Med . 2007;32:201–202.
-
- Gilligan T, Lin DW, Aggarwal R, et al. Testicular cancer, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw . 2019;17:1529–1554.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources